Trexquant Investment LP Biogen Inc. Transaction History

Trexquant Investment LP

  • $8.35 Billion
  • Q2 2025

A detailed history of Trexquant Investment LP transactions in Biogen Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 80,822 shares of BIIB stock, worth $11.8 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
80,822
Previous 44,488 81.67%
Holding current value
$11.8 Million
Previous $6.09 Million 66.75%
% of portfolio
0.12%
Previous 0.08%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$113.38 - $135.49 $4.12 Million - $4.92 Million
36,334 Added 81.67%
80,822 $10.2 Million
Q1 2025

May 14, 2025
BUY
$133.43 - $153.27 $2.82 Million - $3.24 Million
21,151 Added 90.63%
44,488 $6.09 Million
Q4 2024

Feb 12, 2025
SELL
$146.47 - $191.55 $10.7 Million - $14 Million
-73,259 Reduced 75.84%
23,337 $3.57 Million
Q3 2024

Nov 12, 2024
BUY
$189.07 - $236.8 $18.3 Million - $22.9 Million
96,596 New
96,596 $18.7 Million
Q4 2022

Feb 13, 2023
BUY
$252.44 - $306.72 $2.94 Million - $3.57 Million
11,648 Added 172.59%
18,397 $5.09 Million
Q3 2022

Nov 14, 2022
BUY
$194.69 - $268.46 $302,353 - $416,918
1,553 Added 29.89%
6,749 $1.8 Million
Q2 2022

Aug 11, 2022
SELL
$187.54 - $223.02 $2.63 Million - $3.13 Million
-14,014 Reduced 72.95%
5,196 $1.06 Million
Q1 2022

May 13, 2022
BUY
$193.77 - $244.14 $3.72 Million - $4.69 Million
19,210 New
19,210 $4.05 Million
Q4 2021

Feb 14, 2022
SELL
$223.92 - $287.77 $2.02 Million - $2.6 Million
-9,023 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$282.99 - $369.05 $229,221 - $298,930
-810 Reduced 8.24%
9,023 $2.55 Million
Q2 2021

Aug 12, 2021
BUY
$259.0 - $414.71 $2.55 Million - $4.08 Million
9,833 New
9,833 $3.41 Million
Q4 2019

Feb 12, 2020
SELL
$220.06 - $304.07 $554,771 - $766,560
-2,521 Closed
0 $0
Q3 2019

Nov 08, 2019
SELL
$217.44 - $243.88 $1.7 Million - $1.9 Million
-7,811 Reduced 75.6%
2,521 $587,000
Q2 2019

Aug 09, 2019
BUY
$219.29 - $241.72 $2.27 Million - $2.5 Million
10,332 New
10,332 $2.42 Million
Q1 2018

May 03, 2018
SELL
$260.13 - $367.91 $1.65 Million - $2.33 Million
-6,338 Closed
0 $0
Q4 2017

Feb 09, 2018
BUY
$307.64 - $344.58 $1.08 Million - $1.21 Million
3,516 Added 124.59%
6,338 $2.02 Million
Q3 2017

Nov 09, 2017
BUY
$281.15 - $329.69 $793,405 - $930,385
2,822
2,822 $884,000

Others Institutions Holding BIIB

# of Institutions
1,030
Shares Held
131M
Call Options Held
2.84M
Put Options Held
2.54M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email